Cosmax, Inc.
192820.KS
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.48T
Close$
$4914.18
98.3% downside
Current Fair Value
98.3% downsideOvervalued by 98.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.48 Trillion |
|---|---|
| Enterprise Value | $4.23 Trillion |
| Dividend Yield | $3300.00 (1.08%) |
| Earnings per Share | $10846 |
| Beta | 0.77 |
| Outstanding Shares | 11,656,000 |
Return
| Return on Equity | 28.50% |
|---|---|
| Return on Assets | 6.90% |
| Return on Invested Capital | 18.73% |
Valuation & Multiples
| P/E Ratio | 18.09 |
|---|---|
| PEG | 13.63 |
| Price to Sales | 1.25 |
| Price to Book Ratio | 4.67 |
| Enterprise Value to Revenue | 1.59 |
| Enterprise Value to EBIT | 19.33 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 1.68 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$3727.58
Average shareholder expectationRevenue Estimate
$742.02 B
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$2995.15
Average shareholder expectationRevenue Estimate
$803.59 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cosmax, Inc.
1,390 employees
CEO: Jae-Cheon Kim Cosmax, Inc. operates as a global entity engaged in the research, development, manufacturing, and distribution of a broad spectrum of goods, including cosmetic items, nutritional supplements, and pharmaceutical products. Its comprehensiv...